• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Antibacterial and Cytotoxic Actinomycins Y-Y and Zp from Streptomyces sp. Strain Gö-GS12.链霉菌属菌株Gö-GS12产生的抗菌及细胞毒性放线菌素Y-Y和Zp
J Nat Prod. 2016 Oct 28;79(10):2731-2739. doi: 10.1021/acs.jnatprod.6b00742. Epub 2016 Oct 13.
2
First Y-type actinomycins from Streptomyces with divergent structure-activity relationships for antibacterial and cytotoxic properties.首次从链霉菌中分离出具有不同抗菌和细胞毒性构效关系的Y型放线菌素。
Org Biomol Chem. 2009 Feb 7;7(3):444-50. doi: 10.1039/b815689a. Epub 2008 Dec 11.
3
Actinomycins with altered threonine units in the beta-peptidolactone.在β-肽内酯中苏氨酸单元发生改变的放线菌素。
J Nat Prod. 2006 Aug;69(8):1153-7. doi: 10.1021/np060063g.
4
Neo-actinomycins A and B, natural actinomycins bearing the 5H-oxazolo[4,5-b]phenoxazine chromophore, from the marine-derived Streptomyces sp. IMB094.新型放线菌素 A 和 B,一种具有 5H-噁唑并[4,5-b]吩嗪发色团的天然放线菌素,来源于海洋来源的链霉菌 IMB094。
Sci Rep. 2017 Jun 15;7(1):3591. doi: 10.1038/s41598-017-03769-8.
5
A new actinomycin Z analogue with an additional oxygen bridge between chromophore and β-depsipentapeptide from Streptomyces sp. KIB-H714.一种来自链霉菌属KIB-H714的新放线菌素Z类似物,其发色团与β-去甲戊肽之间有一个额外的氧桥。
Nat Prod Res. 2019 Jan;33(2):219-225. doi: 10.1080/14786419.2018.1443097. Epub 2018 Mar 2.
6
Structures of five components of the actinomycin Z complex from Streptomyces fradiae, two of which contain 4-chlorothreonine.来自弗氏链霉菌的放线菌素Z复合物五个组分的结构,其中两个含有4-氯苏氨酸。
J Nat Prod. 2000 Mar;63(3):352-6. doi: 10.1021/np990416u.
7
Cytotoxic antibiotic angucyclines and actinomycins from the Streptomyces sp. XZHG99T.来自链霉菌 XZHG99T 的细胞毒性抗生素安格鲁霉素和放线菌素。
J Antibiot (Tokyo). 2018 Nov;71(12):1018-1024. doi: 10.1038/s41429-018-0096-1. Epub 2018 Aug 29.
8
Isolation, characterization, anti-MRSA evaluation, and in-silico multi-target anti-microbial validations of actinomycin X and actinomycin D produced by novel Streptomyces smyrnaeus UKAQ_23.新型链霉菌 UKAQ_23 产生的放线菌素 X 和放线菌素 D 的分离、鉴定、抗耐甲氧西林金黄色葡萄球菌评估及计算机多靶点抗微生物验证。
Sci Rep. 2021 Jul 15;11(1):14539. doi: 10.1038/s41598-021-93285-7.
9
-Terphenyls and actinomycins from a sp. associated with the larva of mud dauber wasp.一种与泥蜂幼虫有关的 菌所产生的三联苯和放线菌素。
Nat Prod Res. 2021 Jun;35(11):1869-1873. doi: 10.1080/14786419.2019.1639177. Epub 2019 Jul 15.
10
Novel actinomycin group compound from newly isolated Streptomyces sp. RAB12: isolation, characterization, and evaluation of antimicrobial potential.新型放线菌素类化合物,来自新分离的链霉菌 RAB12:分离、鉴定和抗菌潜力评估。
Appl Microbiol Biotechnol. 2018 Feb;102(3):1241-1250. doi: 10.1007/s00253-017-8696-4. Epub 2017 Dec 21.

引用本文的文献

1
Identification and application of a strong bidirectional promoter from actinomycin D-producing streptomycetes.来自产放线菌素D链霉菌的强双向启动子的鉴定与应用。
Eng Microbiol. 2023 Oct 11;4(1):100121. doi: 10.1016/j.engmic.2023.100121. eCollection 2024 Mar.
2
Exploring Indonesian actinomycete extracts for anti-tubercular compounds: Integrating inhibition assessment, genomic analysis, and prediction of its target by molecular docking.探索印度尼西亚放线菌提取物中的抗结核化合物:整合抑制评估、基因组分析以及通过分子对接预测其靶点
Heliyon. 2024 Aug 4;10(15):e35648. doi: 10.1016/j.heliyon.2024.e35648. eCollection 2024 Aug 15.
3
Genome mining of actinomycin shunt products from sp. YINM00002.来自YINM00002菌株的放线菌素分流产物的基因组挖掘
RSC Adv. 2023 Dec 12;13(51):36200-36208. doi: 10.1039/d3ra07277k. eCollection 2023 Dec 8.
4
Oxathiazinane derivatives display both antineoplastic and antibacterial activity: a structure activity study.恶嗪烷衍生物具有抗肿瘤和抗菌活性:构效关系研究。
J Cancer Res Clin Oncol. 2023 Sep;149(11):9071-9083. doi: 10.1007/s00432-023-04799-8. Epub 2023 May 12.
5
Biocontrol of strawberry gray mold caused by with the termite associated sp. sdu1201 and actinomycin D.利用与白蚁相关的sdu1201菌株和放线菌素D对草莓灰霉病进行生物防治。 (注:原文中“with the termite associated sp. sdu1201”表述似乎不太完整规范,但大致意思如上翻译)
Front Microbiol. 2022 Nov 4;13:1051730. doi: 10.3389/fmicb.2022.1051730. eCollection 2022.
6
Genome-Guided Investigation Provides New Insights into Secondary Metabolites of SX6 from .基于基因组的研究为.SX6 中的次生代谢产物提供了新的见解。
Pol J Microbiol. 2022 Sep 24;71(3):381-394. doi: 10.33073/pjm-2022-034. eCollection 2022 Sep 1.
7
Isolation, characterization, anti-MRSA evaluation, and in-silico multi-target anti-microbial validations of actinomycin X and actinomycin D produced by novel Streptomyces smyrnaeus UKAQ_23.新型链霉菌 UKAQ_23 产生的放线菌素 X 和放线菌素 D 的分离、鉴定、抗耐甲氧西林金黄色葡萄球菌评估及计算机多靶点抗微生物验证。
Sci Rep. 2021 Jul 15;11(1):14539. doi: 10.1038/s41598-021-93285-7.
8
Actinomycin V Suppresses Human Non-Small-Cell Lung Carcinoma A549 Cells by Inducing G2/M Phase Arrest and Apoptosis via the p53-Dependent Pathway.放线菌素 V 通过 p53 依赖性途径诱导 G2/M 期阻滞和细胞凋亡抑制人非小细胞肺癌 A549 细胞。
Mar Drugs. 2019 Oct 9;17(10):572. doi: 10.3390/md17100572.
9
Actinomycin V Inhibits Migration and Invasion via Suppressing Snail/Slug-Mediated Epithelial-Mesenchymal Transition Progression in Human Breast Cancer MDA-MB-231 Cells In Vitro.放线菌素 V 通过抑制 Snail/Slug 介导的上皮-间充质转化进程抑制人乳腺癌 MDA-MB-231 细胞的迁移和侵袭 体外。
Mar Drugs. 2019 May 24;17(5):305. doi: 10.3390/md17050305.
10
Identification of the Actinomycin D Biosynthetic Pathway from Marine-Derived SCSIO ZS0073.从海洋来源的 SCSIO ZS0073 中鉴定放线菌素 D 的生物合成途径。
Mar Drugs. 2019 Apr 23;17(4):240. doi: 10.3390/md17040240.

本文引用的文献

1
Crystal Structures of Actinomycin D and Actinomycin Z.放线菌素D和放线菌素Z的晶体结构
Angew Chem Int Ed Engl. 1998 Sep 18;37(17):2381-2384. doi: 10.1002/(SICI)1521-3773(19980918)37:17<2381::AID-ANIE2381>3.0.CO;2-L.
2
Mullinamides A and B, new cyclopeptides produced by the Ruth Mullins coal mine fire isolate Streptomyces sp. RM-27-46.Mullinamides A 和 B,新型环肽,由 Ruth Mullins 煤矿火灾分离得到的链霉菌 RM-27-46 产生。
J Antibiot (Tokyo). 2014 Aug;67(8):571-5. doi: 10.1038/ja.2014.37. Epub 2014 Apr 9.
3
First Y-type actinomycins from Streptomyces with divergent structure-activity relationships for antibacterial and cytotoxic properties.首次从链霉菌中分离出具有不同抗菌和细胞毒性构效关系的Y型放线菌素。
Org Biomol Chem. 2009 Feb 7;7(3):444-50. doi: 10.1039/b815689a. Epub 2008 Dec 11.
4
Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substances.用于确定抗菌物质最低抑菌浓度(MIC)的琼脂稀释法和肉汤稀释法。
Nat Protoc. 2008;3(2):163-75. doi: 10.1038/nprot.2007.521.
5
Actinomycins with altered threonine units in the beta-peptidolactone.在β-肽内酯中苏氨酸单元发生改变的放线菌素。
J Nat Prod. 2006 Aug;69(8):1153-7. doi: 10.1021/np060063g.
6
Clinical studies on actinomycin D with special reference to Wilms' tumor in children.放线菌素D的临床研究,特别涉及儿童肾母细胞瘤。
Ann N Y Acad Sci. 1960 Oct 5;89:421-5. doi: 10.1111/j.1749-6632.1960.tb20165.x.
7
Structures of five components of the actinomycin Z complex from Streptomyces fradiae, two of which contain 4-chlorothreonine.来自弗氏链霉菌的放线菌素Z复合物五个组分的结构,其中两个含有4-氯苏氨酸。
J Nat Prod. 2000 Mar;63(3):352-6. doi: 10.1021/np990416u.
8
A new actinomycin-type chromopeptide from Streptomyces sp. HKI-0155.一种来自链霉菌属HKI-0155菌株的新型放线菌素类色肽。
J Antibiot (Tokyo). 2000 Jan;53(1):84-7. doi: 10.7164/antibiotics.53.84.
9
Selectivity of F8-actinomycin D for RNA:DNA hybrids and its anti-leukemia activity.F8-放线菌素D对RNA:DNA杂交体的选择性及其抗白血病活性。
Bioorg Med Chem. 1997 Jun;5(6):1197-207. doi: 10.1016/s0968-0896(97)00062-x.
10
Structural, physical, and biological characteristics of RNA.DNA binding agent N8-actinomycin D.RNA·DNA结合剂N8-放线菌素D的结构、物理及生物学特性
Biochemistry. 1995 Jul 4;34(26):8481-91.

链霉菌属菌株Gö-GS12产生的抗菌及细胞毒性放线菌素Y-Y和Zp

Antibacterial and Cytotoxic Actinomycins Y-Y and Zp from Streptomyces sp. Strain Gö-GS12.

作者信息

Cai Wenlong, Wang Xiachang, Elshahawi Sherif I, Ponomareva Larissa V, Liu Xiaodong, McErlean Matthew R, Cui Zheng, Arlinghaus Ashley L, Thorson Jon S, Van Lanen Steven G

机构信息

Department of Pharmaceutical Sciences and ‡Center for Pharmaceutical Research and Innovation, College of Pharmacy, University of Kentucky , Lexington, Kentucky 40536, United States.

出版信息

J Nat Prod. 2016 Oct 28;79(10):2731-2739. doi: 10.1021/acs.jnatprod.6b00742. Epub 2016 Oct 13.

DOI:10.1021/acs.jnatprod.6b00742
PMID:27736087
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5217177/
Abstract

Four new Y-type actinomycin analogues named Y-Y (1-4) were isolated and characterized from the scale-up fermentation of the Streptomyces sp. strain Gö-GS12, as well as actinomycin Zp (5), which was, for the first time, isolated as a natural product. Structures of the new compounds were elucidated by the cumulative analyses of NMR spectroscopy and HRMS. The 4-hydroxythreonine on the β-ring of 1 uniquely undergoes both a rearrangement by a 2-fold acyl shift and an additional ring closure with the amino group of the phenoxazinone chromophore, and the α-rings of 4 and 5 contain a rare 5-methyl proline. Compounds 2-5 showed potent antibacterial activities against Gram-positive bacteria that correlated with cytotoxicity against representative human cell lines. The combination of a β-ring rearrangement and additional ring closure in 1 rendered this actinomycin significantly less potent relative to the nonrearranged comparator actinomycin Y and other actinomycins.

摘要

从链霉菌属菌株Gö-GS12的放大发酵中分离并鉴定了四种名为Y-Y(1-4)的新型Y型放线菌素类似物,以及放线菌素Zp(5),后者首次作为天然产物被分离出来。通过核磁共振光谱和高分辨质谱的累积分析阐明了新化合物的结构。化合物1的β环上的4-羟基苏氨酸独特地经历了由2倍酰基转移引起的重排以及与吩恶嗪酮发色团的氨基的额外闭环反应,化合物4和5的α环含有罕见的5-甲基脯氨酸。化合物2-5对革兰氏阳性菌显示出强大的抗菌活性,这与对代表性人类细胞系的细胞毒性相关。化合物1中β环重排和额外闭环的组合使得这种放线菌素相对于未重排的对照放线菌素Y和其他放线菌素的效力显著降低。